78.44 USD
↘ 0.01 (0.01%)PRE MARKET (AS OF 04:38 AM EDT)
Alcon Inc. Ordinary Shares
ALCNYSE • USD
Market: OPEN
Open?$78.20
High?$78.20
Low?$77.58
Prev. Close?$77.82
Volume?1.2K
Avg. Volume?1.4M
VWAP?$77.62
Rel. Volume?0.00x
Bid / Ask
Bid?$77.58 × 200
Ask?$77.64 × 400
Spread?$0.06
Midpoint?$77.61
Valuation & Ratios
Market Cap?37.9B
Shares Out?N/A
P/E Ratio?86.21
P/B Ratio?1.94
EPS?$0.90
Dividend?0.00%
Ex-Dividend?2026-05-06
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.16Strong
Quick Ratio?1.31Adequate
Cash Ratio?0.44Low
Debt/Equity?0.20Low
ValuationFAIRLY VALUED
Score56/100
P/E?86.2PRICEY▾
P/B?1.94CHEAP▾
P/S?4.42FAIR▾
P/FCF?63.5PRICEY▾
EV/EBITDA?27.7HIGH▾
EV/Sales?4.76FAIR▾
Returns & Efficiency
ROE?2.3%WEAK▾
ROA?1.6%WEAK▾
Cash Flow & Enterprise
FCF?$597.0M
Enterprise Value?$40.9B
News
Profile
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.